These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 28393199)
1. Smad4 deletion in blood vessel endothelial cells promotes ovarian cancer metastasis. Yang J; Wang Y; Zeng Z; Qiao L; Zhuang L; Gao Q; Ma D; Huang X Int J Oncol; 2017 May; 50(5):1693-1700. PubMed ID: 28393199 [TBL] [Abstract][Full Text] [Related]
2. Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells. Duda DG; Sunamura M; Lefter LP; Furukawa T; Yokoyama T; Yatsuoka T; Abe T; Inoue H; Motoi F; Egawa S; Matsuno S; Horii A Oncogene; 2003 Oct; 22(44):6857-64. PubMed ID: 14534532 [TBL] [Abstract][Full Text] [Related]
3. The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis. Li Y; Xiao M; Guo F Tumour Biol; 2017 May; 39(5):1010428317705508. PubMed ID: 28475012 [TBL] [Abstract][Full Text] [Related]
4. SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer. Gururajan M; Cavassani KA; Sievert M; Duan P; Lichterman J; Huang JM; Smith B; You S; Nandana S; Chu GC; Mink S; Josson S; Liu C; Morello M; Jones LW; Kim J; Freeman MR; Bhowmick N; Zhau HE; Chung LW; Posadas EM Oncotarget; 2015 Dec; 6(42):44072-83. PubMed ID: 26624980 [TBL] [Abstract][Full Text] [Related]
5. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis. Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973 [TBL] [Abstract][Full Text] [Related]
6. Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines. Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Huang JA; Liu Z Int J Oncol; 2016 Aug; 49(2):700-8. PubMed ID: 27279345 [TBL] [Abstract][Full Text] [Related]
7. Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer. Liu Y; Sheng J; Dai D; Liu T; Qi F Pathol Res Pract; 2015 Apr; 211(4):286-92. PubMed ID: 25680269 [TBL] [Abstract][Full Text] [Related]
8. Roles of Fyn in pancreatic cancer metastasis. Chen ZY; Cai L; Bie P; Wang SG; Jiang Y; Dong JH; Li XW J Gastroenterol Hepatol; 2010 Feb; 25(2):293-301. PubMed ID: 19968749 [TBL] [Abstract][Full Text] [Related]
9. miR-183 modulated cell proliferation and apoptosis in ovarian cancer through the TGF-β/Smad4 signaling pathway. Zhou J; Zhang C; Zhou B; Jiang D Int J Mol Med; 2019 Apr; 43(4):1734-1746. PubMed ID: 30720057 [TBL] [Abstract][Full Text] [Related]
10. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling. Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933 [TBL] [Abstract][Full Text] [Related]
11. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis. Chen IC; Chiang WF; Huang HH; Chen PF; Shen YY; Chiang HC Mol Cancer; 2014 Nov; 13():254. PubMed ID: 25424420 [TBL] [Abstract][Full Text] [Related]
12. Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF. Chen C; Sun MZ; Liu S; Yeh D; Yu L; Song Y; Gong L; Hao L; Hu J; Shao S BMB Rep; 2010 Aug; 43(8):554-60. PubMed ID: 20797318 [TBL] [Abstract][Full Text] [Related]
13. Smad4 inactivation promotes malignancy and drug resistance of colon cancer. Papageorgis P; Cheng K; Ozturk S; Gong Y; Lambert AW; Abdolmaleky HM; Zhou JR; Thiagalingam S Cancer Res; 2011 Feb; 71(3):998-1008. PubMed ID: 21245094 [TBL] [Abstract][Full Text] [Related]
14. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein. Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion. Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161 [TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA MIR4697HG Promotes Cell Growth and Metastasis in Human Ovarian Cancer. Zhang LQ; Yang SQ; Wang Y; Fang Q; Chen XJ; Lu HS; Zhao LP Anal Cell Pathol (Amst); 2017; 2017():8267863. PubMed ID: 28168162 [TBL] [Abstract][Full Text] [Related]
17. USP17 is upregulated in osteosarcoma and promotes cell proliferation, metastasis, and epithelial-mesenchymal transition through stabilizing SMAD4. Song C; Liu W; Li J Tumour Biol; 2017 Jul; 39(7):1010428317717138. PubMed ID: 28670958 [TBL] [Abstract][Full Text] [Related]
18. SIRT1 inhibits TGF-β-induced endothelial-mesenchymal transition in human endothelial cells with Smad4 deacetylation. Li Z; Wang F; Zha S; Cao Q; Sheng J; Chen S J Cell Physiol; 2018 Nov; 233(11):9007-9014. PubMed ID: 29856490 [TBL] [Abstract][Full Text] [Related]